NCT05495334 Innovations in Genicular Outcomes Registry
| NCT ID | NCT05495334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pacira Pharmaceuticals, Inc |
| Condition | Knee Osteoarthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2021-09-23 |
| Primary Completion | 2032-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2021-09-23 with a primary completion date of 2032-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs \[NSAIDs\]).
Eligibility Criteria
Inclusion Criteria: 1. Planned to receive treatment for knee OA pain including, but not limited to, knee injections, nerve blocking procedures, or knee arthroplasty within 60 days of screening 2. Able to understand the informed consent and assessment questionnaires and have the ability to complete them in the opinion of the investigator 3. Have access to a smartphone or internet access with a computer/tablet to complete the questionnaires using the registry application Exclusion Criteria: 1. Actively enrolled in an investigational trial that would preclude patients from receiving the site's standard of care for knee OA pain or knee arthroplasty recovery protocol 2. Planning to have a surgery other than on the target knee
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05495334 clinical trial?
This trial is open to participants of all sexes, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05495334 currently recruiting?
Yes, NCT05495334 is actively recruiting participants. Contact the research team at IGOR@pacira.com for enrollment information.
Where is the NCT05495334 trial being conducted?
This trial is being conducted at Phoenix, United States, Irvine, United States, Los Angeles, United States, DeLand, United States and 11 additional locations.
Who is sponsoring the NCT05495334 clinical trial?
NCT05495334 is sponsored by Pacira Pharmaceuticals, Inc. The trial plans to enroll 10,000 participants.